# A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

> **NCT01426386** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 265 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** FE 999049
- **DRUG:** Gonal - F

## Key facts

- **NCT ID:** NCT01426386
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-04
- **Final completion:** 2013-03
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426386, "A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01426386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*